DSpace JSPUI


DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets

Learn More

Please use this identifier to cite or link to this item: http://repositorio.insp.mx:8080/jspui/handle/20.500.12096/6941
Title: Procalcitonina como biomarcador diagnóstico de sepsis en el niño con cáncer, neutropenia y fiebre: revisión de la literatura
Issue Date: 2015
Abstract: Abstract Among cancer septic patients, there is a deregulation of common events such as inflammation. This fact limits the use of biomarkers to diagnose sepsis. Through a search in the PubMed database, we identified the clinical studies that evaluated procalcitonin as a biomarker among children with cancer sepsis; we analyzed its characteristics, advantages disadvantages. Most of the studies suggest that with a cut off point between 0.5 ng/dl 1 mg/dl, procalcitonin displays a sensitivity of 59 78%, a specificity of 76%, a predictive value of 93% a negative predictive value of 45% to diagnose sepsis. The procalcitonin values were not modified by the use of chemotherapy or steroids. In the past few years, encouraging results have been obtained when using it as a biomarker in children with cancer, particularly with neutropenia fever.
URI: siid.insp.mx:1001-46
http://repositorio.insp.mx:8080/jspui/handle/20.500.12096/6941
Appears in Collections:Artículos

Files in This Item:
File SizeFormat 
com-618854.pdf978.82 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.